Crohn's disease: An immune deficiency state

Clinical Reviews in Allergy and Immunology

Volumn 38, Issue 1, 2010, Pages 20-31

  Marks, Daniel J B ^a   Rahman, Farooq Z ^a   Sewell, Gavin W ^a   Segal, Anthony W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Crohn's disease; Cytokine; Immunodeficiency; Macrophage; Neutrophil

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 12P40; INTERLEUKIN 23 RECEPTOR; ORGANIC CATION TRANSPORTER; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AUTOPHAGY; BACTERIAL INFECTION; CLINICAL FEATURE; CROHN DISEASE; DISCS LARGE HOMOLOG 5 GENE; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; PARATUBERCULOSIS; REVIEW;

ANIMALS; CROHN DISEASE; CYTOKINES; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTESTINAL MUCOSA; MACROPHAGES; MICE; NEUTROPHILS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 75949127130     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8133-2     Document Type: Review

References (92)

1. F Shanahan 2002 Crohn's disease Lancet 359 9300 62 69 10.1016/S0140-6736(02)07284-7 1:CAS:528:DC%2BD38XmsV2muw%3D%3D 11809204 (Pubitemid 34119201)
2. DK Podolsky 2002 Inflammatory bowel disease N Engl J Med 347 6 417 429 10.1056/NEJMra020831 1:CAS:528:DC%2BD38XlvFKrt7s%3D 12167685 (Pubitemid 34851835)
3. AW Segal G Loewi 1976 Neutrophil dysfunction in Crohn's disease Lancet 2 7979 219 221 10.1016/S0140-6736(76)91024-2 1:STN:280:DyaE283hvFWjtA%3D%3D 59239
4. DJ Marks AW Segal 2008 Innate immunity in inflammatory bowel disease: a disease hypothesis J Pathol 214 2 260 266 10.1002/path.2291 1:CAS:528: DC%2BD1cXhvFCkt7c%3D 18161747 (Pubitemid 351160162)
5. JC Barrett, et al. 2008 Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat Genet 40 8 955 962 10.1038/ng.175 1:CAS:528:DC%2BD1cXptFSqs7k%3D 18587394
6. FZ Rahman, et al. 2008 Phagocyte dysfunction and inflammatory bowel disease Inflamm Bowel Dis 14 10 1443 1452 10.1002/ibd.20449 18421761
7. P Rutgeerts, et al. 1991 Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum Lancet 338 8770 771 774 10.1016/0140-6736(91)90663-A 1:STN:280:DyaK38%2Fhs1Olsw%3D%3D 1681159
8. PH Harper, et al. 1985 Role of the faecal stream in the maintenance of Crohn's colitis Gut 26 3 279 284 10.1136/gut.26.3.279 1:STN:280: DyaL2M7ivVGqsg%3D%3D 3972275
9. TK Dalziel 1913 Chronic intestinal enteritis BMJ ii 1068 1070
10. RJ Chiodini, et al. 1984 Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease Dig Dis Sci 29 12 1073 1079 10.1007/BF01317078 1:STN:280:DyaL2M%2FltVKrtw%3D%3D 6499624 (Pubitemid 15181471)
11. M Feller, et al. 2007 Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis Lancet Infect Dis 7 9 607 613 10.1016/S1473-3099(07)70211-6 17714674 (Pubitemid 47268226)
12. P Quirke 2001 Antagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease Gut 49 6 757 760 10.1136/gut.49.6.757 1:STN:280:DC%2BD3MnmtlOitA%3D%3D 11709507 (Pubitemid 33096030)
13. HJ Van Kruiningen 1999 Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans Inflamm Bowel Dis 5 3 183 191 10453375
14. W Selby, et al. 2007 Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease Gastroenterology 132 7 2313 2319 10.1053/j.gastro.2007.03.031 1:CAS:528:DC%2BD2sXnvFOhtLg%3D 17570206 (Pubitemid 46890859)
15. A Darfeuille-Michaud, et al. 2004 High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease Gastroenterology 127 2 412 421 10.1053/j.gastro.2004.04.061 15300573 (Pubitemid 39091889)
16. AL Glasser, et al. 2001 Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death Infect Immun 69 9 5529 5537 10.1128/IAI.69.9.5529-5537. 2001 1:CAS:528:DC%2BD3MXmsVarsrY%3D 11500426 (Pubitemid 32786488)
17. MC Berin, et al. 2002 Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8 Cell Microbiol 4 10 635 648 10.1046/j.1462-5822.2002.00218.x 1:CAS:528:DC%2BD38XotFGlt7w%3D 12366401 (Pubitemid 35214812)
18. S Meconi, et al. 2007 Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro Cell Microbiol 9 5 1252 1261 10.1111/j.1462-5822.2006.00868.x 1:CAS:528:DC%2BD2sXkvFSlsL8%3D 17223928 (Pubitemid 46547142)
19. DJ Marks, et al. 2006 Can unresolved infection precipitate autoimmune disease? Curr Top Microbiol Immunol 305 105 125 10.1007/3-540-29714-6-6 1:CAS:528:DC%2BD28XlvVOjtrk%3D 16724803
20. DN Frank NR Pace 2008 Gastrointestinal microbiology enters the metagenomics era Curr Opin Gastroenterol 24 1 4 10 10.1097/MOG.0b013e3282f2b0e8 1:CAS:528:DC%2BD2sXhtlGgtb%2FF 18043225 (Pubitemid 350190890)
21. M Ainsworth, et al. 1989 Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives Scand J Gastroenterol 24 8 993 998 10.3109/00365528909089246 1:STN:280:DyaK3c%2FosVemsA%3D%3D 2512633
22. D Hollander, et al. 1986 Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor Ann Intern Med 105 6 883 885 1:STN:280:DyaL2s%2FkslWksg%3D%3D 3777713
23. ML Marin, et al. 1983 A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization Am J Gastroenterol 78 9 537 547 1:STN:280:DyaL3szgsFKquw%3D%3D 6613965
24. K Kyo, et al. 2001 Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease J Hum Genet 46 1 5 20 10.1007/s100380170118 1:CAS:528:DC%2BD3MXoslygtA%3D%3D 11289722 (Pubitemid 32178919)
25. MP Buisine, et al. 2001 Mucin gene expression in intestinal epithelial cells in Crohn's disease Gut 49 4 544 551 10.1136/gut.49.4.544 1:CAS:528:DC%2BD3MXotVWgs7Y%3D 11559653 (Pubitemid 32896986)
26. JR Clamp G Fraser AE Read 1981 Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons Clin Sci (Lond) 61 2 229 234 1:CAS:528:DyaL3MXlvVGju7c%3D
27. RD Pullan, et al. 1994 Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis Gut 35 3 353 359 10.1136/gut.35.3.353 1:STN:280:DyaK2c3gtVKlsA%3D%3D 8150346
28. JP Hugot, et al. 1996 Mapping of a susceptibility locus for Crohn's disease on chromosome 16 Nature 379 6568 821 823 10.1038/379821a0 1:CAS:528:DyaK28XhsVWlu7Y%3D 8587604 (Pubitemid 26067722)
29. JP Hugot, et al. 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 6837 599 603 10.1038/35079107 1:CAS:528:DC%2BD3MXksVShtLY%3D 11385576 (Pubitemid 32531408)
30. Y Ogura, et al. 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 6837 603 606 10.1038/35079114 1:CAS:528:DC%2BD3MXksVShur8%3D 11385577 (Pubitemid 32531409)
31. AP Cuthbert, et al. 2002 The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease Gastroenterology 122 4 867 874 10.1053/gast.2002.32415 1:CAS:528:DC%2BD38XjtFOmtbY%3D 11910337
32. Y Ogura, et al. 2001 Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB J Biol Chem 276 7 4812 4818 10.1074/jbc.M008072200 1:CAS:528:DC%2BD3MXhtlOqtL8%3D 11087742
33. O Gutierrez, et al. 2002 Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation J Biol Chem 277 44 41701 41705 10.1074/jbc.M206473200 1:CAS:528:DC%2BD38XotF2gs78%3D 12194982 (Pubitemid 35257477)
34. S Lala, et al. 2003 Crohn's disease and the NOD2 gene: a role for paneth cells Gastroenterology 125 1 47 57 10.1016/S0016-5085(03)00661-9 1:CAS:528:DC%2BD3sXmtVWqtbs%3D 12851870 (Pubitemid 36799106)
35. SE Girardin, et al. 2003 Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection J Biol Chem 278 11 8869 8872 10.1074/jbc.C200651200 1:CAS:528:DC%2BD3sXhvVyqsbs%3D 12527755 (Pubitemid 36800360)
36. N Inohara, et al. 2003 Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease J Biol Chem 278 8 5509 5512 10.1074/jbc.C200673200 1:CAS:528:DC%2BD3sXht1aqsro%3D 12514169 (Pubitemid 36800790)
37. J Li, et al. 2004 Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations Hum Mol Genet 13 16 1715 1725 10.1093/hmg/ddh182 1:CAS:528:DC%2BD2cXlvFGqsbo%3D 15198989 (Pubitemid 39173441)
38. DJ Marks, et al. 2006 Defective acute inflammation in Crohn's disease: a clinical investigation Lancet 367 9511 668 678 10.1016/S0140-6736(06)68265-2 1:CAS:528:DC%2BD28XhslylsbY%3D 16503465 (Pubitemid 43289157)
39. JD Rioux, et al. 2007 Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis Nat Genet 39 5 596 604 10.1038/ng2032 1:CAS:528: DC%2BD2sXksFersbk%3D 17435756 (Pubitemid 46676115)
40. P Borgiani, et al. 2007 Interleukin-23R Arg381Gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population Gastroenterology 133 3 1049 1051 10.1053/j.gastro.2007.07.013 1:CAS:528:DC%2BD2sXhtFars7%2FN 17854611 (Pubitemid 47374149)
41. RK Weersma, et al. 2009 Confirmation of multiple Crohn's Disease susceptibility loci in a large Dutch-Belgian cohort Am J Gastroenterol 104 3 630 638 10.1038/ajg.2008.112 1:CAS:528:DC%2BD1MXis1arur8%3D 19174780
42. KJ Maloy 2008 The interleukin-23/interleukin-17 axis in intestinal inflammation J Intern Med 263 6 584 590 10.1111/j.1365-2796.2008.01950.x 1:CAS:528:DC%2BD1cXnvVOltb4%3D 18479257 (Pubitemid 351678587)
43. LM Stuart RA Ezekowitz 2005 Phagocytosis: elegant complexity Immunity 22 5 539 550 10.1016/j.immuni.2005.05.002 1:CAS:528:DC%2BD2MXkslOqsLk%3D 15894272 (Pubitemid 40719190)
44. P Kuballa, et al. 2008 Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant PLoS ONE 3 10 e3391 10.1371/journal.pone.0003391 18852889
45. SB Singh, et al. 2006 Human IRGM induces autophagy to eliminate intracellular mycobacteria Science 313 5792 1438 1441 10.1126/science.1129577 1:CAS:528:DC%2BD28XptFWju7o%3D 16888103 (Pubitemid 44360272)
46. HP Torok, et al. 2005 Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease Gut 54 10 1421 1427 10.1136/gut.2005.066340 15955786 (Pubitemid 41375199)
47. JD Rioux, et al. 2001 Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease Nat Genet 29 2 223 228 10.1038/ng1001-223 1:CAS:528:DC%2BD3MXnsFKnsrk%3D 11586304 (Pubitemid 32952663)
48. VD Peltekova, et al. 2004 Functional variants of OCTN cation transporter genes are associated with Crohn disease Nat Genet 36 5 471 475 10.1038/ng1339 1:CAS:528:DC%2BD2cXjsFSntrg%3D 15107849 (Pubitemid 38620030)
49. H Nakamura, et al. 1998 Identification of a novel human homolog of the Drosophila dlg, P-dlg, specifically expressed in the gland tissues and interacting with p55 FEBS Lett 433 1-2 63 67 10.1016/S0014-5793(98)00882-5 1:CAS:528:DyaK1cXltlemsb4%3D 9738934 (Pubitemid 28386733)
50. B Maher 2008 Personal genomes: the case of the missing heritability Nature 456 7218 18 21 10.1038/456018a 1:CAS:528:DC%2BD1cXhtlCjtrnM 18987709
51. S Kuramoto, et al. 1987 Granulomas of the gut in Crohn's disease. A step sectioning study Dis Colon Rectum 30 1 6 11 10.1007/BF02556910 1:STN:280:DyaL2s7gsV2juw%3D%3D 3803110
52. DG James 2000 A clinicopathological classification of granulomatous disorders Postgrad Med J 76 898 457 465 10.1136/pmj.76.898.457 1:CAS:528:DC%2BD3cXlvFeksrw%3D 10908370 (Pubitemid 30636109)
53. EP Reeves, et al. 2002 Killing activity of neutrophils is mediated through activation of proteases by K+ flux Nature 416 6878 291 297 10.1038/416291a 1:CAS:528:DC%2BD38XisFSmtrg%3D 11907569 (Pubitemid 34260237)
54. AJ Thrasher, et al. 1994 Chronic granulomatous disease Biochim Biophys Acta 1227 1-2 1 24 1:CAS:528:DyaK2cXmslOltLo%3D 7918677
55. DJ Marks, et al. 2009 Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease Am J Gastroenterol 104 1 117 124 10.1038/ajg.2008.72 1:CAS:528:DC%2BD1MXht1Shsw%3D%3D 19098859
56. E Ishii, et al. 1987 Chediak-Higashi syndrome with intestinal complication. Report of a case J Clin Gastroenterol 9 5 556 558 10.1097/00004836-198710000-00015 1:STN:280:DyaL1c%2FmtVegsg%3D%3D 3680907
57. AL Grucela, et al. 2006 Granulomatous enterocolitis associated with Hermansky-Pudlak syndrome Am J Gastroenterol 101 9 2090 2095 10.1111/j.1572-0241.2006.00733.x 16848805 (Pubitemid 44337635)
58. C O'Morain AW Segal AJ Levi 1984 Elemental diet as primary treatment of acute Crohn's disease: a controlled trial Br Med J (Clin Res Ed) 288 6434 1859 1862 10.1136/bmj.288.6434.1859
59. JM Rhodes, et al. 1982 Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis Gastroenterology 82 6 1327 1334 1:STN:280:DyaL387msFCrtQ%3D%3D 6978274
60. RJ Farrell MA Peppercorn 2002 Ulcerative colitis Lancet 359 9303 331 340 10.1016/S0140-6736(02)07499-8 11830216 (Pubitemid 34119301)
61. MW Harbord, et al. 2006 Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor Aliment Pharmacol Ther 24 4 651 660 10.1111/j.1365-2036.2006.03016.x 1:CAS:528:DC%2BD28XpslWjsLY%3D 16907898 (Pubitemid 44127847)
62. W Strober IJ Fuss RS Blumberg 2002 The immunology of mucosal models of inflammation Annu Rev Immunol 20 495 549 10.1146/annurev.immunol.20.100301. 064816 1:CAS:528:DC%2BD38XjtlWgtLk%3D 11861611 (Pubitemid 34293433)
63. SR Vavricka, et al. 2004 hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells Gastroenterology 127 5 1401 1409 10.1053/j.gastro.2004.07.024 1:CAS:528:DC%2BD2cXhtVKisrzE 15521010 (Pubitemid 39457767)
64. SL Doyle LA O'Neill 2006 Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity Biochem Pharmacol 72 9 1102 1113 10.1016/j.bcp.2006.07.010 1:CAS:528: DC%2BD28XhtVagtr%2FK 16930560 (Pubitemid 44468394)
65. DJ Marks, et al. 2006 An exuberant inflammatory response to E. coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosum Gut 55 11 1662 1663 10.1136/gut.2006.104943 1:STN:280:DC%2BD28nhtlChug%3D%3D 17047113 (Pubitemid 44629220)
66. JV Castell, et al. 1989 Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes FEBS Lett 242 2 237 239 10.1016/0014-5793(89)80476-4 1:CAS:528:DyaL1MXntlKksw%3D%3D 2464504 (Pubitemid 19020112)
67. S Bridger, et al. 2002 In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis Gut 51 1 21 25 10.1136/gut.51.1.21 1:STN:280:DC%2BD38zmtFKmsQ%3D%3D 12077086 (Pubitemid 34717738)
68. M Sopori 2002 Effects of cigarette smoke on the immune system Nat Rev Immunol 2 5 372 377 10.1038/nri803 1:CAS:528:DC%2BD38Xjsl2rs7o%3D 12033743
69. ME Sher, et al. 1999 The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease Inflamm Bowel Dis 5 2 73 78 1:STN:280:DyaK1M3mvVKqtA%3D%3D 10338374
70. JP Hugot, et al. 2003 Crohn's disease: the cold chain hypothesis Lancet 362 9400 2012 2015 10.1016/S0140-6736(03)15024-6 1:CAS:528:DC%2BD3sXpvVWku74%3D 14683664 (Pubitemid 37548429)
71. AH Liu JR Murphy 2003 Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol 111 3 471 478 10.1067/mai.2003.172 12642824 (Pubitemid 36337864)
72. DE Elliott, et al. 2000 Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J 14 12 1848 1855 10.1096/fj.99-0885hyp 1:CAS:528:DC%2BD3cXms1Cltro%3D 10973934
73. RW Summers, et al. 2005 Trichuris suis therapy in Crohn's disease Gut 54 1 87 90 10.1136/gut.2004.041749 1:STN:280:DC%2BD2cnhslWnsw%3D%3D 15591509 (Pubitemid 40007223)
74. MJ Farthing 2004 Bugs and the gut: an unstable marriage Best Pract Res Clin Gastroenterol 18 2 233 239 10.1016/j.bpg.2003.11.001 15123066 (Pubitemid 38444128)
75. CK Porter, et al. 2008 Infectious gastroenteritis and risk of developing inflammatory bowel disease Gastroenterology 135 3 781 786 10.1053/j.gastro.2008. 05.081 18640117
76. W Bednarz, et al. 2008 Analysis of results of surgical treatment in Crohn's disease Hepatogastroenterology 55 84 998 1001 18705315
77. BE Scammell MR Keighley 1986 Delayed perineal wound healing after proctectomy for Crohn's colitis Br J Surg 73 2 150 152 10.1002/bjs.1800730226 1:STN:280:DyaL287jt1ersg%3D%3D 3947907
78. J Kyle 1980 Urinary complications of Crohn's disease World J Surg 4 2 153 160 10.1007/BF02393564 1:STN:280:DyaL3c3mtFaktA%3D%3D 7405253 (Pubitemid 10022109)
79. NS Ambrose J Alexander-Williams MR Keighley 1984 Audit of sepsis in operations for inflammatory bowel disease Dis Colon Rectum 27 9 602 604 10.1007/BF02553851 1:STN:280:DyaL2c3osVylsw%3D%3D 6468201
80. SM Hutfless, et al. 2007 Mortality by medication use among patients with inflammatory bowel disease, 1996-2003 Gastroenterology 133 6 1779 1786 10.1053/j.gastro.2007.09.022 18054550 (Pubitemid 350180814)
81. DW Gilroy, et al. 2004 Inflammatory resolution: new opportunities for drug discovery Nat Rev Drug Discov 3 5 401 416 10.1038/nrd1383 1:CAS:528:DC%2BD2cXktlCrt7w%3D 15136788
82. IK Nahar, et al. 2003 Infliximab treatment of rheumatoid arthritis and Crohn's disease Ann Pharmacother 37 9 1256 1265 10.1345/aph.1C039 1:CAS:528:DC%2BD3sXnsFCms78%3D 12921510 (Pubitemid 37040219)
83. G Cui, et al. 2006 Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use Scand J Clin Lab Invest 66 3 249 259 10.1080/00365510600590472 1:CAS:528:DC%2BD28XmtVOhtr0%3D 16714253 (Pubitemid 43994988)
84. S Dionne, et al. 1997 Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies Dig Dis Sci 42 7 1557 1566 10.1023/A:1018895500721 1:STN:280:DyaK2szovVygsg%3D%3D 9246063 (Pubitemid 27339380)
85. A Stallmach, et al. 2004 Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease Int J Colorectal Dis 19 4 308 315 10.1007/s00384-003-0554-4 14605835 (Pubitemid 38868295)
86. SE Plevy, et al. 1997 A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease J Immunol 159 12 6276 6282 1:CAS:528:DyaK1cXht1Whsw%3D%3D 9550432
87. WJ Sandborn, et al. 2001 Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial Gastroenterology 121 5 1088 1094 10.1053/gast.2001.28674 1:CAS:528:DC%2BD3MXpt1SrsLk%3D 11677200
88. JM Van den Brande, et al. 2003 Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease Gastroenterology 124 7 1774 1785 10.1016/S0016-5085(03)00382-2 12806611 (Pubitemid 36666774)
89. Y Naito, et al. 2003 Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice J Gastroenterol Hepatol 18 5 560 569 10.1046/j.1440-1746.2003.03034.x 1:CAS:528: DC%2BD3sXkslyjtLo%3D 12702049 (Pubitemid 36645291)
90. J Oh DG Arkfeld DA Horwitz 2005 Development of Crohn's disease in a patient taking etanercept J Rheumatol 32 4 752 753 15801037
91. G Charach I Grosskopf M Weintraub 2008 Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone Digestion 77 3-4 198 200 10.1159/000143156 18607107
92. S Saverymuttu HJ Hodgson VS Chadwick 1985 Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease Gut 26 10 994 998 10.1136/gut.26.10.994 1:STN:280: DyaL28%2FjtFCqsw%3D%3D 3902590